≥99% Peptide Purity: How to Verify the Claim (Complete Verification Guide)

Quick answer

A ≥99% purity claim means that at least 99% of the peptide-related material in a sample is the target sequence, measured as peak area on a reverse-phase HPLC chromatogram. It says nothing about how much of the vial is peptide by mass. A 99% pure peptide can still be only 75% peptide, with the rest being counterion salt and water.

The five-minute supplier audit

Before the explanation, here is the checklist. It works on any supplier's Certificate of Analysis, including ours.

Fewer than seven passes means you cannot verify what you are buying. That is the whole test. Everything below explains why each line matters and what a failure actually costs you.

Key takeaways

• HPLC purity is a relative measurement — the target peak as a percentage of all peaks the detector can see.
• Trifluoroacetate counterions, residual water, and mannitol lyoprotectant are invisible at the 214–220 nm wavelengths used for peptide HPLC.
• Net peptide content is the separate figure that tells you how much of the powder is actually peptide. For TFA-salt peptides it typically runs 70–90%.
• A vial labelled 10 mg at 80% net peptide content holds roughly 8 mg of peptide. Every concentration calculation downstream inherits that 20% gap.
• HPLC proves separation. Mass spectrometry proves identity. Neither substitutes for the other, and a COA with only one is incomplete.
• Most impurities in synthetic peptides are deletion and insertion sequences from solid-phase synthesis — molecules that differ from the target by one amino acid and can be genuinely difficult to resolve.
• A purity figure without the wavelength, column, and gradient conditions is not a verifiable measurement.
• A supplier claiming ≥99% on every item in a large catalogue deserves scrutiny, because long and hydrophobic sequences are harder to purify than short ones.

Definitions

HPLC purity is the target peptide's peak area expressed as a percentage of total integrated peak area on a reverse-phase chromatogram, measured at a specified UV wavelength. It quantifies how much of the UV-absorbing material is the correct sequence.

Net peptide content (NPC) is the percentage of the lyophilized powder's total mass that is peptide, as opposed to counterions, residual moisture, and excipients. It is determined by quantitative amino acid analysis or nitrogen determination, not by HPLC.

A Certificate of Analysis (COA) is a lot-specific analytical record documenting identity, purity, and physical characteristics of a manufactured batch. A COA that is not tied to a specific lot certifies nothing about the vial in your hand.

A counterion is the ionic species that pairs with charged residues on a peptide. Reverse-phase purification with trifluoroacetic acid leaves peptides as TFA salts unless an exchange step is performed.

What does ≥99% purity actually certify?

A ≥99% purity figure certifies that the target peptide accounts for at least 99% of the integrated peak area on an HPLC chromatogram at a specified wavelength. It is a measure of how well the correct sequence was separated from incorrect ones. It is not a measure of how much peptide is in the vial.

That distinction is the single most consequential thing to understand about peptide purity, and most product pages never mention it.

What the measurement includes

Reverse-phase HPLC pushes a dissolved sample through a column that separates molecules by hydrophobicity. A UV detector — typically set to 214 or 220 nm, where the peptide bond absorbs, sometimes cross-checked at 280 nm for aromatic residues — records what comes off the column and when. The result is a chromatogram: a baseline with peaks.

Purity is calculated by integrating the area under every peak and expressing the target peak as a percentage of that total.

What the measurement excludes

Here is the part that catches people out. The detector only sees what absorbs UV at the chosen wavelength. Several things in a peptide vial do not:

None of these are impurities in the sense of "wrong peptide." They are simply not peptide. And because they are invisible to the instrument doing the measuring, they do not lower the purity figure by a single decimal place.

The practical consequence

A vial can legitimately carry a 99.4% purity certificate and contain 75% peptide by mass. Both numbers are true. They answer different questions.

If your work involves receptor-binding assays, IC₅₀ determinations, or any calculation where milligrams matter, purity alone will not get you there. You need the second number.

Purity versus net peptide content: the number that changes your math

Net peptide content is the percentage of the lyophilized powder that is actually peptide. For TFA-salt peptides it typically falls between 70% and 90%, depending on how many basic residues the sequence contains. Purity and net peptide content are independent measurements, and a complete COA reports both.

Why basic residues drive the figure

TFA binds to positively charged sites: the free N-terminus, and the side chains of lysine, arginine, and histidine. Each bound counterion adds 114 Da of non-peptide mass. A sequence rich in basic residues therefore carries proportionally more salt — regardless of how well it was purified.

The theoretical figure can be estimated directly:

Theoretical NPC = MW ÷ (MW + n × 114)

MW = peptide molecular weight in Da
n = number of basic sites requiring a counterion

Theoretical net peptide content by molecular weight and basic-site count

Read the bottom-left cell. A short, basic-rich peptide can be under two-thirds peptide by mass before you account for water. That is not a quality failure. It is chemistry, and it is why the measured figure matters.

Note that this calculation assumes counterions are the only non-peptide component. In practice, residual moisture and solvents push the real figure lower still, which is why the measured value from amino acid analysis is what belongs on a COA.

What an 80% figure does to your calculations

Take a vial labelled 10 mg, reconstituted with 2 mL of bacteriostatic water.

Every downstream figure inherits that error — concentration, aliquot mass, syringe unit conversions, the lot. Our reconstitution and syringe unit conversion reference covers the arithmetic; this is the input it depends on.

One more thing about counterions

The counterion is not only a mass question. TFA at elevated concentrations has been reported to interfere with certain cell-based assays, which is why laboratories doing that work often request acetate or hydrochloride salt forms specifically. If your protocol is sensitive, ask before you order rather than after.

How to read a Certificate of Analysis, field by field

A complete peptide COA documents sequence, molecular weight, HPLC purity with method conditions, mass spectrometry confirmation, net peptide content, counterion form, appearance, lot number, and test date. Fields that are absent are not omissions of convenience — each one closes a specific question about what is in the vial.

Reading the chromatogram itself

If a chromatogram image is provided, three things are worth a look even without analytical training:

Peak shape. The main peak should be sharp and symmetrical. Pronounced tailing suggests column interaction or sample issues.

Shoulders. A bump on the side of the main peak usually indicates a partially resolved impurity — often a deletion sequence differing by a single residue. A shoulder can hide material that integration folds into the main peak, inflating the reported purity.

Baseline. It should be flat and quiet between peaks. A drifting or noisy baseline makes integration less reliable.

Run length. A gradient that ends too early can leave late-eluting hydrophobic impurities on the column, where they never appear in the integration at all.

How to tell whether a COA is real

The most common problems with peptide COAs are not forgeries but reuse: a single document presented for multiple lots, or a template with a lot number typed in. Genuine lot-specific documentation includes analytical raw data — a chromatogram and a mass spectrum — that cannot be plausibly fabricated for every batch.

This section exists because the question comes up constantly and almost nobody answers it directly.

Signals that a COA is genuinely lot-specific

• The chromatogram is unique. Two lots of the same peptide produce visibly different traces — retention times shift slightly, impurity peaks vary. Identical chromatograms across lots is the clearest tell.
• The reported purity is not a round number. Real integration returns 99.14%, not 99%. A catalogue where every product reads exactly "99%" is reporting a specification, not a measurement.
• Test dates track manufacturing dates. A COA dated before its lot was produced, or years after, has been repurposed.
• The MS observed mass has decimals and sits within a stated tolerance of theoretical — not simply equal to it.

How to check independently

Contact the testing laboratory. Accredited third-party labs will confirm whether they issued a specific report number. This takes one email and settles the question entirely.

Ask for a second lot's COA. Compare the two documents. If the chromatograms are identical, you have your answer.

Verify the molecular weight yourself. Sum the residue masses for the stated sequence and add 18 Da for water. If the theoretical MW on the COA does not match the sequence printed above it, the document was not built from that peptide. Our research peptide glossary covers the notation if the sequence code is unfamiliar.

Request the raw data file. Suppliers with genuine analytics can usually provide the instrument output. Suppliers without them cannot.

HPLC and mass spectrometry: what each one proves

HPLC separates the sample and quantifies how much of it is the target peak. Mass spectrometry measures molecular mass and confirms the peptide is the sequence claimed. Purity without identity is meaningless, because a perfectly purified wrong molecule passes an HPLC test with full marks.

Why both are required

Consider two failure modes. In the first, a supplier ships the correct peptide at 92% purity. HPLC catches it; MS looks fine. In the second, a supplier ships a well-purified but incorrect sequence. HPLC reports 99.6%; only MS catches the error.

A COA with one test and not the other leaves one of those doors open.

What neither test covers

Mass spectrometry cannot distinguish stereoisomers. A D-amino acid substitution from racemization during synthesis has the same mass as the L-form and can co-elute closely. Detecting it requires chiral analysis or NMR, which sits outside routine research-grade QC. This is a genuine limit of standard documentation, and it is worth knowing rather than assuming the two standard tests cover everything.

Our complete guide to peptide purity testing and verification works through the analytical methods in more depth.

Where peptide impurities come from

Most impurities in synthetic peptides originate during solid-phase peptide synthesis. Deletion sequences arise from incomplete coupling, insertion sequences from excess reagent, and racemization from the deprotection step. Additional impurities form through degradation and interaction with excipients after synthesis.¹

Understanding the sources explains why some peptides are simply harder to purify than others — and why a blanket ≥99% claim across an entire catalogue is a claim worth testing.

The main categories

Deletion sequences. A coupling step fails and one amino acid is missing from the chain. The resulting molecule differs from the target by a single residue, which often means it elutes very close to the target peak. These are the impurities most likely to hide in a shoulder.

Insertion sequences. Excess amino acid reagent produces a chain with a residue added.

Truncated sequences. Synthesis terminates early, leaving a shorter chain.

Diastereomeric impurities. Racemization during Fmoc deprotection converts an L-residue to D. Same mass, different molecule, invisible to MS.

Protection adducts. Side-chain protecting groups are incompletely removed, or scavenger reagents attach during cleavage.

Degradation products. Oxidation of methionine, cysteine, or tryptophan; deamidation of asparagine and glutamine; hydrolysis at aspartate. These accumulate with poor storage rather than poor synthesis.

Why sequence difficulty varies so much

Not all peptides are equally purifiable. Length works against you, because each additional coupling step is another chance for a deletion. Hydrophobic stretches aggregate on the resin and couple poorly. Sequences containing arginine, histidine, tryptophan, or cysteine present their own problems.

A ten-residue peptide and a forty-residue peptide are not comparable manufacturing tasks. That reality is exactly why the next section treats a universal ≥99% claim with caution.

Third-party testing versus in-house testing

Third-party testing means an independent accredited laboratory with no commercial interest in the result performs the analysis. In-house testing means the manufacturer or distributor tests its own material. Both can be accurate. Only one removes the conflict of interest from the equation.

The honest position on this

In-house testing is not inherently untrustworthy. Large manufacturers run sophisticated analytical departments, and their internal QC is frequently better than a budget contract lab's.

The issue is not capability. It is verifiability. When a supplier tests its own product and publishes the result, you are being asked to trust the reporting as well as the testing. Third-party documentation lets you check.

A reasonable middle ground, and the one most credible research suppliers occupy: in-house testing on every lot for routine QC, plus periodic third-party confirmation, with both published. What you should push back on is a supplier that cannot name the laboratory at all.

Purity tiers and what they mean in practice

Research peptides are commonly specified at ≥95%, ≥98%, or ≥99% purity. The tier appropriate for a given study depends on what the work is sensitive to — a preliminary screen tolerates impurity levels that a quantitative binding assay does not.

The uncomfortable part

A supplier claiming ≥99% purity across every item in a large catalogue is making a claim that runs against manufacturing reality. Long sequences, hydrophobic sequences, and sequences with difficult residues resist purification. Achieving ≥99% consistently across all of them is expensive and, for some, impractical.

This applies to us too. Our name states a standard we hold ourselves to, and the only thing that makes such a claim meaningful is lot-specific documentation you can inspect. A brand name is a promise. A chromatogram with a matching lot number is evidence. Ask any supplier — including this one — for the second thing.

Matching the tier to the work

• Does your readout depend on absolute concentration? You need ≥98% or better, plus net peptide content.
• Are you comparing conditions within one experiment? A consistent lot matters more than the last percentage point.
• Is this a reference standard or a published result? Take the highest available tier and full third-party documentation.
• Is this early-stage screening? ≥95% may be entirely appropriate, and paying for more is not always the better decision.

Our buyer's guide to choosing high-purity research peptides walks through the tier decision in more detail.

Nine supplier red flags

The clearest warning signs are missing lot-specific documentation, purity claims without method conditions, and identical chromatograms across different batches. Each indicates that the analytical claim cannot be independently checked.

1. No COA available before purchase. Documentation supplied only after payment is not documentation you can evaluate.
2. A generic COA with no lot number. It describes some batch. Possibly not yours.
3. Purity stated without wavelength, column, or gradient. An unverifiable number.
4. No chromatogram image. The figure exists without its evidence.
5. Identical chromatograms across lots. One analysis, reused.
6. Every product reads exactly ≥99%. A specification presented as a measurement.
7. No net peptide content anywhere on the site or the COA. Either not measured, or not disclosed.
8. The testing laboratory is unnamed. Nobody is accountable for the numbers.
9. Therapeutic or dosing claims on a research-grade product. A supplier willing to misrepresent regulatory status is telling you how it handles other claims.

None of these individually proves a supplier is unreliable. Three or more together is a pattern.

What to ask a supplier — copy-paste email

The fastest way to evaluate a supplier is to request specific analytical documentation and see what comes back. A supplier with genuine lot-level QC answers within a day. One without will send marketing copy, or nothing.

Send this before you order. It works on any vendor.

Subject: Analytical documentation request — [PEPTIDE NAME]

Hello,

I'm evaluating [PEPTIDE NAME] for laboratory research use and would
like to review documentation before ordering. Could you provide the
following for the lot currently shipping:

1. Lot-specific Certificate of Analysis (not a generic template)
2. HPLC purity, including wavelength, column, gradient, and flow rate
3. The chromatogram image for this lot
4. Mass spectrometry result: method, observed mass, theoretical mass
5. Net peptide content, and the method used to determine it
6. Counterion form (TFA, acetate, or HCl)
7. Water content by Karl Fischer, if measured
8. Name of the testing laboratory and the report number
9. Full sequence in one- or three-letter code
10. Lot manufacturing date and test date

If a second lot's COA is also available, I'd appreciate seeing that
alongside for comparison.

Thank you,
[NAME]
[INSTITUTION / LAB]

How to read the reply

Full documentation within 24–48 hours. The supplier has lot-level analytics and expects to be asked.

Partial documentation with an explanation. Reasonable. Net peptide content by amino acid analysis is not universal on research-grade COAs, and a supplier saying so plainly is being straight with you.

A marketing response that answers none of the ten items. You have learned what you needed to.

Silence. Same conclusion, arrived at more slowly.

How we document our own material

Every 99 Purity Peptides lot ships with reverse-phase HPLC and mass spectrometry documentation tied to that specific batch number. All certificates are published openly in our certificate library rather than being supplied on request, so the documentation can be inspected before purchase.

We have written this page to be usable against us. That is deliberate. A purity claim from a company named after purity is worth precisely nothing on its own — the checklist at the top of this page is the thing that has value, and it should be applied here as readily as anywhere else.

What you will find on our certificates: lot number matched to the vial, HPLC purity with method conditions and chromatogram, mass spectrometry identity confirmation with observed and theoretical mass, sequence, appearance, and test date.

What is not on every certificate: net peptide content by quantitative amino acid analysis. AAA is a separate assay with meaningful per-sample cost and it is not standard across research-grade suppliers. Where you need it for quantitative work, ask us for the specific lot and we will tell you plainly whether we have it. We would rather say so here than have you discover it on a COA.

Related resources

References

1. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2–30. PubMed 25044089 · doi:10.1016/j.jpba.2014.06.012
2. Giri S, et al. Regulatory considerations in synthetic peptide characterization: techniques and compliance. Separation Science Plus. 2025. doi:10.1002/sscp.70057
3. Quality control of amino acids and peptides: a guide. Bachem. bachem.com
4. Peptide quality — frequently asked questions, including net peptide content determination. AAPPTEC. peptide.com

Methodology. Analytical descriptions on this page reflect standard practice in synthetic peptide quality control as documented in the peer-reviewed and industry sources cited above. The theoretical net peptide content table was calculated using the counterion mass formula (MW ÷ [MW + n × 114]) and independently verified. Typical mass-share ranges for counterions, moisture, and excipients reflect commonly reported industry figures and will vary by sequence and manufacturer.

Editorial policy. 99 Purity Peptides content is reviewed before publication and updated when analytical standards, regulatory guidance, or product specifications change. Corrections are logged with the update date.

Research transparency. Lot-matched certificates for all current material are published in our certificate library. Where a specific analysis is not routinely performed, we say so rather than omitting the field.

A note on this page. This is an educational overview, not individualized guidance. We source the figures above from the peer-reviewed and industry literature cited in the references, and we encourage you to verify any claim — ours included — against a supplier's actual lot documentation rather than taking a percentage on trust.

Research Use Only. All materials referenced are supplied for laboratory research purposes. They are not drugs, foods, cosmetics, or medical devices, and are not for human or veterinary use.